CDISC Therapeutic Area Data Standards: User Guide for Breast Cancer (Version 1.0 Provisional) Page 56 © 2016 Clinical Data Interchange Standards Consortium, Inc. All rights reserved May 16, 2016 Provisional Row STUDYID USUBJID ASEQ ASTDT ASTDY PARQUAL PARAMCD AVALC ANL01FL 19 ABC -123 ABC -123-002 5 2013DEC01 19 INVESTIGATOR ASSESS SD Y 20 ABC -123 ABC -123-002 6 2013DEC02 20 CENTRAL ASSESS SD Y 21 ABC -123 ABC -123-002 7 2013DEC14 32 PROTOCOL EVENT MED PROCEED 22 ABC -123 ABC -123-002 8 2013DEC27 45 INVESTIGATOR ASSESS PR 23 ABC -123 ABC -123-002 9 2013DEC28 46 CENTRAL ASSESS PR 24 ABC -123 ABC -123-002 10 2013DEC29 47 PROTOCOL DISPOSIT TREATMENT 5.3.3 Efficacy Analysis Datasets Once the ADEVENT dataset is created, a BDS dataset can be constructed to extract the critical data from that dataset for use in creating the tables in Section 5.2. The following ADaM dataset is an e xample for creating the time- to-event ana lysis table descr ibed above. ADTTE Variable Metadata Variable Name Variable Label Type Codelist/ Controlled Terms Notes STUDYID Study Identifier Char ADSL .STUDYID USUBJID Unique Subject Identifier Char ADSL .USUBJID ASEQ Analysis Sequence Number Num Sequential number for associating a record number in the ADEVENT dataset. Unique number per subject per parameter per parameter qualifier per analysis start date. PARQUAL Parameter Qualifier Char INVESTIGATOR ; CENTRAL; PATHOLOGIC; PROTOCOL This identifies the source of the Parameter. Investigator for investigator based assessments ; Central for central imaging assessments ; Pathologic for an assessment by biopsy ; and Protocol for events affecting assessment. PARAM Parameter Char Progression -free Survival ; Overal l Survival ; Duration of Response These are the parameters used for efficacy analysis. PARAMCD Parameter Code Char PFS; OS; DOR If progression -free survival , then set to ‘PFS .’ If overall survival , then set to ‘OS .’ If duration of response , then set to ‘DOR .’ AVAL Analysis Value Num The numeric value representing the time from the reference start date to the date of the analysis. (Where an analysis may be either an assessment, disposition, or event recorded as documented in ADEVENT.) PARAM CD = ‘PFS’: ADVENT.ASTDY when ADEVENT.ANL01FL = ‘Y and ADVENT.PARAMCD = ‘ASSESS’ and disease progressed. PARAMCD = ‘OS’: ADVENT.ASTDY when ADEVENT .ANL01FL = ‘Y’ and ADVENT.PARAMCD = ‘EVENT’ and ADVENT.AVALC = ‘DEATH’ or when ADEVENT.ANL01FL = ‘Y’ and ADVENT.PARAMCD = ‘ DISPOSIT ’ and maximum ADEVENT.ASTDY. PARAMCD = ‘DOR: Time from best response to when disease progressed. CNSR Censored Num 1; 0 Censoring Value. Set to 1 if value is censored based on rules. PARAMCD = ‘PFS’: If disease did not progress, then CNSR = 1. PARAMCD = ‘OS’: If subject did not die, then CNSR = 1. Proposed Proposed